osteoporosis

Merck Says Jury Rules in Its Favor in Fosamax Trial

Merck Says Jury Rules in Its Favor in Fosamax Trial

Bloomberg

Merck Starts Fresh Trial on Fosamax Broken-Leg Claims

Merck Starts Fresh Trial on Fosamax Broken-Leg Claims

Bloomberg

Merck’s Fosamax on Trial Again After First Case Halted

Merck’s Fosamax on Trial Again After First Case Halted

Bloomberg

Merck Hid Fosamax’s Bone-Weakening Risks, Lawyer Contends

Merck Hid Fosamax’s Bone-Weakening Risks, Lawyer Contends

Bloomberg

Unigene Faces Do-or-Die FDA Panel Tuesday

Unigene Faces Do-or-Die FDA Panel Tuesday

Yahoo/TheStreet.com

Amgen, UCB halt testing of drug for fracture healing, but continue testing for osteoporosis

Amgen, UCB halt testing of drug for fracture healing, but continue testing for osteoporosis

Yahoo/AP

Merck loses 'bellwether' Fosamax case

Merck loses 'bellwether' Fosamax case

Fierce Pharma

Merck Earnings Call Nuggets: Outcome of IMPROVE-IT and Filing Odanacatib

Merck Earnings Call Nuggets: Outcome of IMPROVE-IT and Filing Odanacatib

Wall Street Cheat Street

Unigene Welcomes FDA Advisory Committee Review of Salmon Calcitonin

Unigene Welcomes FDA Advisory Committee Review of Salmon Calcitonin

Yahoo

Will Merck's Odanacatib Sufficiently Fill Singulair's Void?

Will Merck's Odanacatib Sufficiently Fill Singulair's Void?

Motley Fool